zafirlukast
Development- Indications
- Asthma
Company intelligence / Profile preview
Hovione does not develop its own clinical-stage drugs but provides development and manufacturing services for both innovative and generic pharmaceutical products. It has contributed to the approval of numerous new drugs through its contract work with pharma/biotech partners. Its proprietary generics portfolio includes market-leading antibiotics like doxycycline and corticosteroids such as dexamethasone dipropionate.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hovione.